Brief: BioScrip Inc Says Reaffirming Guidance For 2019 Adjusted EBITDA Of At Least $75 Mln
01/11/2018 12:17
Nov 1 (Reuters) - BioScrip Inc BIOS.O :
* BIOSCRIP INC - REAFFIRMING GUIDANCE FOR 2019 ADJUSTED
EBITDA OF
AT LEAST $75 MILLION
Source text for Eikon: ID:nGNX8ZKJmK
Further company coverage: BIOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Option Care Health
See all newsU.S. RESEARCH ROUNDUP- Cencora, Crocs, Teledyne Technologies
U.S. STOCKS ON THE MOVE-AerCap Holdings, Salesforce, Emcor Group
U.S. STOCKS ON THE MOVE-Cheesecake Factory, SiriusPoint, Arcutis Biosciences
U.S. STOCKS ON THE MOVE-Instacart, Spotify, First Solar
Option Care Health says UnitedHealth hack may hit financials in near term (updated)